In the original publication [1], there was a mistake in Figure 1A as published. The two upper-right images were repeated unintentionally in the neighboring boxes. In addition, the control figures on the left side overlapped. Figure 1A has been corrected and appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 1.
188ReO4 IC50 dose finding on Huh7 and HepG2 cell lines. Huh7 cells viability was measured using LIVE/DEAD® Viability/Cytotoxicity Kit and the mean viability of untreated cells (control group), and the treated groups were compared on various doses of 18, 37, and 55 MBq of 188ReO4 at 18, 24, and 48 h post-exposure for finding the effective dose of 188ReO4 (A–C). HepG2 cells viability was measured using LIVE/DEAD® Viability/Cytotoxicity Kit in response to 37, 55, and 73 MBq of 188ReO4 18, 24, and 48 h post-exposure for finding the effective dose of 188ReO4 in treated HepG2 cells (D–F). The IC50 value of 188ReO4 in Huh7 cells was 37 MBq 24 h after exposure, and it was 55 MBq 48 h for HepG2 cells. Data are presented as the mean ± SD, n = 3 (* p < 0.05, ** p < 0.01, and *** p < 0.001, **** p < 0.0001).
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Asadian S., Piryaei A., Gheibi N., Aziz Kalantari B., Reza Davarpanah M., Azad M., Kapustina V., Alikhani M., Moghbeli Nejad S., Keshavarz Alikhani H., et al. Rhenium Perrhenate (188ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells. Cells. 2022;11:305. doi: 10.3390/cells11020305. [DOI] [PMC free article] [PubMed] [Google Scholar]